• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    2/14/23 7:34:59 AM ET
    $PANA
    Blank Checks
    Finance
    Get the next $PANA alert in real time by email
    SC 13G/A 1 d406303dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Panacea Acquisition Corp. II

    (Name of Issuer)

    Class A ordinary shares, par value $0.0001 per share

    (Title of Class of Securities)

    G6882C106

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. G6882C106

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Maverick Capital, Ltd. – 75-2482446

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     

      (a)  ☐        (b)  ☐

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Texas

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,385,250

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,385,250

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,385,250

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IA


    CUSIP No. G6882C106

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Maverick Capital Management, LLC – 75-2686461

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     

      (a)  ☐        (b)  ☐

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Texas

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,385,250

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,385,250

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,385,250

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      HC


    CUSIP No. G6882C106

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Lee S. Ainslie III

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     

      (a)  ☐        (b)  ☐

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      SOLE VOTING POWER

     

      0

       6   

      SHARED VOTING POWER

     

      1,385,250

       7   

      SOLE DISPOSITIVE POWER

     

      0

       8   

      SHARED DISPOSITIVE POWER

     

      1,385,250

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,385,250

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.8%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN


    Item 1(a).

    Name of Issuer:

    Panacea Acquisition Corp. II

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    357 Tehama Street, Floor 3

    San Francisco, CA 94103

     

    Item 2(a).

    Names of Persons Filing:

    This Schedule 13G (the “Schedule 13G”) is being filed on behalf of each of the following persons (each, a “Reporting Person”):

     

      (i)

    Maverick Capital, Ltd.;

     

      (ii)

    Maverick Capital Management, LLC; and

     

      (iii)

    Lee S. Ainslie III (“Mr. Ainslie”).

    The Schedule 13G relates to Ordinary Shares (as defined herein) held for the accounts of Maverick Capital, Ltd.’s clients.

     

    Item 2(b).

    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons is:

    The address of the principal business office of (i) Maverick Capital, Ltd. and Maverick Capital Management, LLC is 1900 N. Pearl Street, 20th Floor, Dallas, Texas 75201, and (ii) Mr. Ainslie is 360 South Rosemary Avenue, Suite 1440, West Palm Beach, Florida 33401.

     

    Item 2(c).

    Citizenship:

     

      (i)

    Maverick Capital, Ltd. is a Texas limited partnership;

     

      (ii)

    Maverick Capital Management, LLC is a Texas limited liability company; and

     

      (iii)

    Mr. Ainslie is a citizen of the United States.

     

    Item 2(d).

    Title of Class of Securities:

    Class A ordinary shares, par value $0.0001 per share (“Ordinary Shares”)

     

    Item 2(e).

    CUSIP Number:

    G6882C106


    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e)    ☒    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
    (g)    ☒    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    (h)    ☐    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
    (i)    ☐    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
    (j)    ☐    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    Item 4.

    Ownership.

    Ownership as of December 31, 2022 is incorporated by reference to items (5) – (9) and (11) of the cover page of the Reporting Person.

    Maverick Capital, Ltd. is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940 and, as such, may be deemed to have beneficial ownership of the Ordinary Shares which are the subject of this filing through the investment discretion it exercises over its clients’ accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd. Mr. Ainslie is the manager of Maverick Capital Management, LLC.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.


    Item 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certification.

    By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Date: February 14, 2023
    MAVERICK CAPITAL, LTD.
    By:   Maverick Capital Management, LLC, its General Partner
    By:   Lee S. Ainslie III, Manager
    By:   /s/ Mark Gurevich
      Mark Gurevich
      Under Power of Attorney dated March 15, 2018
    MAVERICK CAPITAL MANAGEMENT, LLC
    By:   Lee S. Ainslie III, Manager
    By:   /s/ Mark Gurevich
      Mark Gurevich
      Under Power of Attorney dated March 15, 2018
    LEE S. AINSLIE III
    By:   /s/ Mark Gurevich
      Mark Gurevich
      Under Power of Attorney dated March 15, 2018


    EXHIBIT INDEX

     

    A.

    Joint Filing Agreement, dated February 14, 2023, by and among Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie III.

     

    B.

    Power of Attorney, Lee S. Ainslie III, dated March 15, 2018.

     

    Get the next $PANA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PANA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PANA
    SEC Filings

    View All

    SEC Form 15-12G filed by Panacea Acquisition Corp. II

    15-12G - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/28/23 1:18:26 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Panacea Acquisition Corp. II

    25-NSE - Panacea Acquisition Corp. II (0001828989) (Subject)

    4/18/23 4:29:11 PM ET
    $PANA
    Blank Checks
    Finance

    Panacea Acquisition Corp. II filed SEC Form 8-K: Other Events

    8-K - Panacea Acquisition Corp. II (0001828989) (Filer)

    4/10/23 4:11:09 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company

    NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of its business combination with Panacea Acquisition Corp. (NYSE: PANA), a special purpose acquisition company (SPAC) sponsored by EcoR1 Capital. The resulting combined company will commence trading its shares on the New York Stock Exchange (NYSE) under the ticker symbol "NUVB" on February 11, 2021. The business combination was approved by Panacea's shareholders on February 9, 2021 and was previously approved by Nuvation Bio shareholders. Nuvation Bio's man

    2/10/21 4:05:00 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ecor1 Panacea Holdings Ii, Llc

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    5/2/23 5:15:46 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 4: EcoR1 Panacea Holdings II, LLC bought $5,450,000 worth of Class A ordinary shares (545,000 units at $10.00)

    4 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/13/21 3:10:13 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form 3 filed by Llc Ii, Holdings Panacea Ecor1

    3 - Panacea Acquisition Corp. II (0001828989) (Issuer)

    4/6/21 8:37:38 PM ET
    $PANA
    Blank Checks
    Finance

    $PANA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/24 4:01:16 PM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 8:02:36 AM ET
    $PANA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Panacea Acquisition Corp. II (Amendment)

    SC 13G/A - Panacea Acquisition Corp. II (0001828989) (Subject)

    2/14/23 7:34:59 AM ET
    $PANA
    Blank Checks
    Finance